FDA Inspection
Fresenius Kabi Austria GMBHFresenius Kabi Austria GMBH – FDA Inspection, Mar 28, 2023
Record Details
This FDA Inspection record concerns Fresenius Kabi Austria GMBH, with an inspection on March 28, 2023, issued by the Office of Inspections and Investigations.
- Company
- Fresenius Kabi Austria GMBH
- Inspection Date
- March 28, 2023
View Company Profile
ID · 3f14ff02-d1dd-4c9e-88dd-b03f51c88db8
Inspection Facts
- Inspection number
- 1205334
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Fresenius Kabi Austria GMBH
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2018 | Not classified | Office of Inspections and Investigations | |
| February 8, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi Austria GMBH
- FDA Inspection 1251340 - 2024-03-21
- FDA Inspection 1207391 - 2022-10-13
- FDA Inspection 1162216 - 2020-01-30
- FDA Inspection 1052462 - 2018-04-19
- FDA Inspection 1094504 - 2018-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.